Annual sales fell 11.2 percent from KRW 499.3 billion in 2022 to KRW 443.2 billion in 2023, then rose 7.5 percent to KRW 476.6 billion in 2024 and 3.4 percent to KRW 492.7 billion in 2025, increasing for two straight years from 2024 to 2025. 2022 was the largest year for sales and 2023 the smallest.
Operating profit was KRW 22.8 billion in 2022, KRW 15.6 billion in 2023 (down 31.9 percent), KRW 23 billion in 2024 (up 48.0 percent) and KRW 20.3 billion in 2025 (down 11.7 percent), with 2024 the largest year.
The operating margin moved from 4.6 percent in 2022 to 3.5 percent in 2023, 4.8 percent in 2024 and 4.1 percent in 2025, so margins fell in 2025 even as sales grew.
Net profit attributable to controlling shareholders was KRW 20.2 billion in 2022, KRW 13.2 billion in 2023 (down 34.5 percent), KRW 25.3 billion in 2024 (up 91.1 percent) and KRW 26.2 billion in 2025 (up 3.6 percent), with 2025 the largest year.
Net profit including non-controlling interests was KRW 30.4 billion in 2025, and the gap reflects the non-controlling share.
At the end of 2025, total equity was KRW 326.7 billion, of which KRW 289.5 billion belonged to controlling shareholders, and total liabilities were KRW 201.2 billion; the debt ratio fell from 89.6 percent in 2022 to 61.6 percent in 2025.
Operating cash flow was KRW 23.1 billion in 2022, KRW 21.4 billion in 2023, KRW 12.4 billion in 2024 and KRW 28.6 billion in 2025.
On a quarterly basis, sales were KRW 128.2 billion in the third quarter of 2025, KRW 118 billion in the fourth quarter (down 7.9 percent quarter on quarter), KRW 147.7 billion in the first quarter of 2026, KRW 160.5 billion in the second quarter and KRW 153.9 billion in the third quarter (down 4.1 percent quarter on quarter, up 20.0 percent year on year).
Operating profit fell to KRW 2.23 billion in the fourth quarter of 2025, then recovered to KRW 9.28 billion in the first quarter of 2026 and KRW 17.5 billion in the second quarter, before dropping to KRW 7.58 billion in the third quarter (down 56.6 percent quarter on quarter, up 9.7 percent year on year).
Net profit attributable to controlling shareholders was KRW 9.06 billion in the third quarter of 2025, KRW 2.08 billion in the fourth quarter, KRW 13.6 billion in the first quarter of 2026, KRW 27.5 billion in the second quarter and KRW 2.18 billion in the third quarter, which was down 76.0 percent year on year.
The second quarter's controlling-shareholder profit exceeded its operating profit, so the composition of non-operating items is a point to verify in the 2026 annual report.
Bizwatch reported in September 2026 that the subsidiary Miwon Specialty Chemical posted first-half 2026 sales of KRW 304.1 billion, up 11.5 percent, and operating profit of KRW 56.4 billion, up 51.6 percent; these are subsidiary-level figures and differ from the holding company's consolidated results.